Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
BCL2A1 encodes a member of the BCL-2 protein family. Zusätzlich bieten wir Ihnen BCL2-Related Protein A1 Proteine (12) und BCL2-Related Protein A1 Kits (8) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 102 products:
Human Polyclonal BCL2A1 Primary Antibody für IHC, ELISA - ABIN1001894
Lockshin, Osborne, Zakeri: Cell death in the third millennium. in Cell death and differentiation 2000
Show all 4 Pubmed References
Human Polyclonal BCL2A1 Primary Antibody für ELISA, WB - ABIN1001895
Kim, Kim, Lee, Lim, Cho, Yoon, Cho, Baek, Park, Paik, Choe, Lee: Up-regulation of Bfl-1/A1 via NF-kappaB activation in cisplatin-resistant human bladder cancer cell line. in Cancer letters 2004
Show all 4 Pubmed References
Human Polyclonal BCL2A1 Primary Antibody für WB - ABIN223123
Zaehringer, Sapoval, Pattynama, Rabbia, Vignali, Maleux, Boyer, Szczerbo-Trojanowska, Jaschke, Hafsahl, Downes, Beregi, Veeger, Stoll, Talen: Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): angiographic follow-up after 6 months and clinical outcome up to 2 years. in Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists 2007
Show all 3 Pubmed References
Human Polyclonal BCL2A1 Primary Antibody für ELISA, WB - ABIN4283619
Hosgood, Zhang, Shen, Berndt, Vermeulen, Li, Yin, Yeager, Yuenger, Rothman, Chanock, Smith, Lan: Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. in Occupational and environmental medicine 2009
Human Polyclonal BCL2A1 Primary Antibody für ELISA, ICC - ABIN4283621
Ovadje, Ammar, Guerrero, Arnason, Pandey: Dandelion root extract affects colorectal cancer proliferation and survival through the activation of multiple death signalling pathways. in Oncotarget 2016
The findings support a model in which survival is determined by quantitative participation of multiple anti-apoptotic proteins, BCL2 (zeige BCL2 Antikörper), Mcl1 (zeige MCL1 Antikörper), and BCL2A1, rather than by a single anti-apoptotic protein.
This dynamic change in B cell survival mechanisms is unique to Epstein-Barr virus-infected cells and relies on regulation of MCL-1 (zeige MCL1 Antikörper) mitochondrial localization and BFL-1 transcription by the viral EBNA3A (zeige EBNA-3A Antikörper) protein.
Loss of A1 alone does not impair T cell-driven immune responses. It therefore appears likely that A1 has critical overlapping functions with other pro-survival BCL-2 (zeige BCL2 Antikörper) proteins in T cell immune responses.
Overexpression of BCL2A1 in T lymphocytes causes selective impairment of TH17 differentiation and protection against autoimmune arthritis.
Constitutive expression of the anti-apoptotic molecule Bfl1 (A1) in murine vascular Endothelial Cells leads to prolonged allograft survival due to modifying inflammation.
Findings identify BCL2A/A1 as a MYC (zeige MYC Antikörper) target that can be induced prematurely during B cell development to aid expansion of otherwise cell-death-prone MYC (zeige MYC Antikörper) transgenic pre-B cells
Conditional knockdown of BCL2A1 reveals rate-limiting roles in BCR (zeige BCR Antikörper)-dependent B-cell survival.
Knockdown of the antiapoptotic Bcl-2 (zeige BCL2 Antikörper) family member A1/Bfl-1 protects mice from anaphylaxis.
Bcl2a1 should be considered as a proto-oncogene (zeige RAB1A Antikörper) with a potential role in both lymphoid and myeloid leukemogenesis
A subset of Bcl2 (zeige BCL2 Antikörper) family proteins are the targets of FGF-2 (zeige FGF2 Antikörper) signaling that promotes the survival of ATDC5 cells.
Demonstrate immunohistochemical expression of Wnt11 (zeige WNT11 Antikörper) and BCL2A1 in complete moles and normal villi.
Bfl-1 was mitochondrially resident in both resting and apoptotic cells and experienced regulation by the proteasome and NFkappaB pathways.
Bcl2a1 overexpressing granulocytic MDSCs demonstrated prolonged survival.
Results indicate that mismatches in minor H antigens HA-8 (KIAA0020) and ACC-1 (BCL2A1) predisposed to chronic graft-versus-host disease (GvHD).
BCL2A1 is a novel marker associated with seizure prognosis following surgery for low-grade brain neoplasms.
MITF (zeige MITF Antikörper)-BCL2A1 as a lineage-specific oncogenic pathway in melanoma and underscore its role for improved response to BRAF (zeige BRAF Antikörper)-directed therapy.
Mitochondrial antiapoptotic factor Bfl-1 is significantly reduced by suppressor of cytokine signaling (SOCS (zeige CISH Antikörper))1 (zeige SOCS1 Antikörper).
results highlight Bfl-1 as a major effector in activation-induced human mast cell survival
Data indicate that BCL2a1 expression enhances tumor cell survival in nervous system (CNS) leading to intracranial tumor growth.
a high-level expression of BCL2A1 in the conceptus at Day 21 of gestation, and it was expressed and increased in the extraembryonic membrane, cotyledon, and intercotyledon from implantation to term.
regulation of A1 and Bak contribute to mitochondrial membrane stability, reduced caspase-9 activity, and delayed apoptosis in bovine neutrophils exposed to glucocorticoids
This gene encodes a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. The protein encoded by this gene is able to reduce the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation. This gene is a direct transcription target of NF-kappa B in response to inflammatory mediators, and is up-regulated by different extracellular signals, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), CD40, phorbol ester and inflammatory cytokine TNF and IL-1, which suggests a cytoprotective function that is essential for lymphocyte activation as well as cell survival. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
bcl-2-related protein A1
, protein A1
, Bcl-2-like protein 5
, BCL2-related protein A1
, Bcl-2-related protein A1
, B-cell leukemia/lymphoma 2 related protein A1a
, hemopoietic-specific early response protein
, protein BFL-1
, bcl-2-like protein 5
, hematopoietic BCL2-related protein A1
, B-cell leukemia/lymphoma 2 related protein A1
, B-cell leukemia/lymphoma 2 related protein A1d
, BCL2-related protein A1d